| Apple Music Taps TuneIn to Expand Global Access to Its Live Radio Stations |
Globe Newswire |
08/27 |
10:09 |
| DraftKings Launches Responsible Gaming Education Month Campaign Featuring Super Bowl Tickets Sweepstakes |
Globe Newswire |
08/26 |
07:30 |
| Marker Therapeutics Provides Update on Phase 1 APOLLO Study Highlighting Encouraging Overall Response Rates in Relapsed Lymphoma |
Globe Newswire |
08/26 |
07:00 |
| Rally House Expands in Twelve Oaks Mall |
Globe Newswire |
08/25 |
10:06 |
| TuneIn Announces Comprehensive Division 1 College Football Coverage for the 2025–2026 Season |
Globe Newswire |
08/21 |
09:01 |
| Inspired and bet365 Launch Next-Gen Virtual Sports: V-Play NHL, NBA Re-Play, and Re-Play eSports |
Globe Newswire |
08/20 |
09:02 |
| Sportradar Strengthens Bundesliga International Relationship With Launch of Innovative New Products Starting 2025-26 Season |
Globe Newswire |
08/19 |
06:00 |
| Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001 |
Globe Newswire |
08/15 |
16:15 |
| DraftKings Secures Direct Mobile Sports Betting License to Operate in Missouri |
Globe Newswire |
08/15 |
11:33 |
| Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update |
Globe Newswire |
08/12 |
16:05 |
| Flutter Entertainment: Q2 2025 Update |
Globe Newswire |
08/07 |
16:05 |
| Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2025 Financial Results |
Globe Newswire |
08/07 |
16:01 |
| Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) |
Globe Newswire |
08/07 |
10:30 |
| C4 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights |
Globe Newswire |
08/07 |
07:00 |
| DraftKings Reports Second Quarter Revenue Growth of 37% to $1,513 Million |
Globe Newswire |
08/06 |
16:15 |
| Arvinas Reports Second Quarter 2025 Financial Results and Provides Corporate Update |
Globe Newswire |
08/06 |
07:00 |
| Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma |
Globe Newswire |
08/06 |
01:30 |
| Sportradar Reports Second Quarter Financial Results and Raises Full Year 2025 Outlook |
Globe Newswire |
08/05 |
07:00 |
| Cellectis Reports Second Quarter 2025 Financial Results & Business Updates |
Globe Newswire |
08/04 |
16:30 |
| FanDuel Sports Network Scales Live Sports Monetization with Magnite |
Globe Newswire |
07/30 |
08:00 |
| CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm |
Globe Newswire |
07/25 |
19:35 |
| Non-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight |
Globe Newswire |
07/24 |
13:00 |
| Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update |
Globe Newswire |
07/23 |
16:01 |
| BetOnline Expands Sportsbook Betting Site Services and Product Offerings for California Users |
Globe Newswire |
07/23 |
10:23 |
| Rogers Communications Reports Second Quarter 2025 Results |
Globe Newswire |
07/23 |
07:00 |
